122024-71-9Relevant articles and documents
PROTEIN KINASE D INHIBITORS
-
Page/Page column 49, (2012/06/30)
Compounds according to Formula (I), are potent inhibitors of protein kinase D (pan-PKD) activity. PKD controls key signaling cascades in cells, affecting cell proliferation, gene transcription, and protein trafficking. Accordingly, pharmaceutically acceptable compositions of the inventive compounds are candidate therapeutics for pathological conditions conditioned by changes in PKD activity.
Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents
Connor,Cetenko,Mullican,Sorenson,Unangst,Weikert,Adolphson,Kennedy,Thueson,Wright,Conroy
, p. 958 - 965 (2007/10/02)
The synthesis and antiallergic activity of a series of novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles are described. A number of the compounds inhibit the release of histamine from anti-IgE stimulated basophils obtained from alle